These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20852369)

  • 1. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F; Ahmed TM; Samina U
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J; Kryński J
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
    Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A; Polito C; Del Gado R; Foglia AC
    Child Nephrol Urol; 1988-1989; 9(4):200-2. PubMed ID: 3255483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS; Shien CY; Chi CS
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J; Jankowski A; Szozda A
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):455-9. PubMed ID: 8170809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.